MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications

被引:0
作者
Reena V. Kartha
Subbaya Subramanian
机构
[1] University of Minnesota,Department of Pharmaceutics
[2] University of Minnesota,Department of Laboratory Medicine and Pathology
[3] University of Minnesota Medical School,Department of Laboratory Medicine and Pathology
来源
Journal of Cardiovascular Translational Research | 2010年 / 3卷
关键词
Heart; MicroRNA; Cardiovascular Diseases; Diagnostics; Therapeutics;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiovascular diseases represent one of the major causes for increasing rates of human morbidity and mortality across the world. This reinforces the necessity for the development of novel diagnostics and therapies for the early identification and cure of heart diseases. MicroRNAs are evolutionarily conserved small regulatory non-coding RNAs that regulate the expression of large number of genes. They are involved in several cellular pathophysiological pathways and have been shown to play a significant role in the pathogenesis of many disease states. Recent studies have correlated dysregulated miRNA expressions to diseased hearts and also shown the relevance of miRNA in growth, development, function, and stress responsiveness of the heart. The possibility of exploiting miRNAs to develop diagnostic markers or manipulating them to obtain therapeutic effects is very attractive since they have very specific targets in a particular cellular pathway. In this review we will summarize the role played by miRNAs in the heart and discuss the scope of utilizing miRNA-based strategies in the clinics for the benefit of mankind.
引用
收藏
页码:256 / 270
页数:14
相关论文
共 689 条
[11]  
Lu Y.(2005)A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia New England Journal of Medicine 353 1793-1801
[12]  
Jiao J.(2009)MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice Journal of Clinical Investigation 119 2772-2786
[13]  
Altuvia Y(2008)Taking microRNAs to heart Trends in Molecular Medicine 14 254-260
[14]  
Landgraf P(2007)MicroRNA-133 controls cardiac hypertrophy Nature Medicine 13 613-618
[15]  
Lithwick G(2006)The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nature Genetics 38 228-233
[16]  
Elefant N(2008)Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 997-1006
[17]  
Pfeffer S(2007)MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? American Journal of Pathology 170 1831-1840
[18]  
Aravin A(2009)MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation Circulation Research 105 158-166
[19]  
Asangani IA(2008)Detection and characterization of placental microRNAs in maternal plasma Clinical Chemistry 54 482-490
[20]  
Rasheed SA(2006)A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep Nature Genetics 38 813-818